CTI BioPharma
CTIC
#5622
Rank
S$1.55 B
Marketcap
S$11.78
Share price
0.00%
Change (1 day)
26.62%
Change (1 year)

CTI BioPharma (CTIC) - Cash on Hand

Cash on Hand as of March 2023 : S$76.47 Million

According to CTI BioPharma 's latest financial reports the company has S$76.47 Million in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

CTI BioPharma - Cash on Hand chart (from 1997 to 2023)

Cash on Hand by year

Year Cash on Hand Change
2022-12-31S$0.10 B21.12%
2021-12-31S$88.47 M27.51%
2020-12-31S$69.38 M52.88%
2019-12-31S$45.38 M-50.44%
2018-12-31S$91.58 M58.44%
2017-12-31S$57.8 M-9.23%
2016-12-31S$63.68 M-64.88%
2015-12-31S$0.18 B93.45%
2014-12-31S$93.72 M3.26%
2013-12-31S$90.76 M47.16%
2012-12-31S$61.67 M1.22%
2011-12-31S$60.93 M108.86%
2010-12-31S$29.17 M-45.04%
2009-12-31S$53.08 M247.84%
2008-12-31S$15.26 M-42.19%
2007-12-31S$26.39 M-68.02%
2006-12-31S$82.55 M-28.02%
2005-12-31S$0.11 B-39.33%
2004-12-31S$0.18 B21.49%
2003-12-31S$0.15 B-36.06%
2002-12-31S$0.24 B-48.64%
2001-12-31S$0.47 B76.48%
2000-12-31S$0.26 B574.67%
1999-12-31S$39.79 M447.79%
1998-12-31S$7.26 M-51.59%
1997-12-31S$15 M94.94%
1996-12-31S$7.69 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
Amgen
AMGN
S$12.23 B 15,905.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
S$21.38 B 27,864.28%๐Ÿ‡บ๐Ÿ‡ธ USA
Incyte
INCY
S$3.79 B 4,864.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Baxter
BAX
S$2.23 B 2,824.88%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
S$12.84 B 16,699.41%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
S$2.85 B 3,633.20%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Novartis
NVS
S$12.63 B 16,427.43%๐Ÿ‡จ๐Ÿ‡ญ Switzerland